ATE242629T1 - Neue behandlungsmethode unter verwendung einer hochdosierten form von amoxycillin und kaliumclavulanat - Google Patents

Neue behandlungsmethode unter verwendung einer hochdosierten form von amoxycillin und kaliumclavulanat

Info

Publication number
ATE242629T1
ATE242629T1 AT00303033T AT00303033T ATE242629T1 AT E242629 T1 ATE242629 T1 AT E242629T1 AT 00303033 T AT00303033 T AT 00303033T AT 00303033 T AT00303033 T AT 00303033T AT E242629 T1 ATE242629 T1 AT E242629T1
Authority
AT
Austria
Prior art keywords
amoxycillin
treatment method
high dose
dose form
new treatment
Prior art date
Application number
AT00303033T
Other languages
English (en)
Inventor
Kevin Storm
Creighton Conley
John Roush
Original Assignee
Beecham Pharm Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27383840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE242629(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Pharm Pte Ltd filed Critical Beecham Pharm Pte Ltd
Application granted granted Critical
Publication of ATE242629T1 publication Critical patent/ATE242629T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
AT00303033T 1999-04-13 2000-04-11 Neue behandlungsmethode unter verwendung einer hochdosierten form von amoxycillin und kaliumclavulanat ATE242629T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12907499P 1999-04-13 1999-04-13
US15072799P 1999-08-25 1999-08-25
US15981399P 1999-10-15 1999-10-15

Publications (1)

Publication Number Publication Date
ATE242629T1 true ATE242629T1 (de) 2003-06-15

Family

ID=27383840

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00303033T ATE242629T1 (de) 1999-04-13 2000-04-11 Neue behandlungsmethode unter verwendung einer hochdosierten form von amoxycillin und kaliumclavulanat
AT0027900U AT4327U1 (de) 1999-04-13 2000-04-11 Pharmazeutische formulierung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT0027900U AT4327U1 (de) 1999-04-13 2000-04-11 Pharmazeutische formulierung

Country Status (45)

Country Link
EP (4) EP1270005A3 (de)
JP (2) JP4880125B2 (de)
KR (1) KR100634937B1 (de)
CN (1) CN100382782C (de)
AP (1) AP1806A (de)
AR (1) AR031068A1 (de)
AT (2) ATE242629T1 (de)
AU (1) AU767177B2 (de)
BE (2) BE1013309A5 (de)
BG (1) BG65006B1 (de)
BR (1) BRPI0009719B8 (de)
CA (1) CA2366304C (de)
CO (1) CO5170471A1 (de)
CZ (1) CZ298801B6 (de)
DE (3) DE10017883A1 (de)
DK (3) DK1044680T3 (de)
DZ (1) DZ3150A1 (de)
EA (1) EA004310B1 (de)
ES (2) ES2202004T3 (de)
FI (2) FI20000863A (de)
FR (1) FR2792198A1 (de)
GB (1) GB2351661B (de)
GR (1) GR1003560B (de)
HK (1) HK1032741A1 (de)
HU (1) HU229097B1 (de)
IE (1) IE20000271A1 (de)
IL (2) IL145580A0 (de)
IT (1) ITMI20000788A1 (de)
MA (1) MA25352A1 (de)
MX (1) MXPA01010377A (de)
MY (1) MY119953A (de)
NL (2) NL1014914C1 (de)
NO (1) NO329694B1 (de)
NZ (1) NZ514575A (de)
OA (1) OA11926A (de)
PE (1) PE20010053A1 (de)
PL (1) PL197448B1 (de)
PT (2) PT102450B (de)
RO (1) RO120817B1 (de)
SE (1) SE0001330L (de)
SI (2) SI1044680T1 (de)
SK (1) SK285140B6 (de)
TR (1) TR200102963T2 (de)
TW (1) TWI235067B (de)
WO (1) WO2000061116A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
JP3501289B2 (ja) * 1995-09-07 2004-03-02 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 医薬処方
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (de) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Amoxicillinhaltige arzneizusammensetzungen
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
EP1406630A1 (de) 2001-07-06 2004-04-14 Endo Pharmaceuticals Inc. Parenterale verabreichung von hydroxy-oxymorphon als analgetikum
GB0117618D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
ATE419840T1 (de) 2002-04-09 2009-01-15 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
NZ536267A (en) * 2002-04-10 2007-06-29 Fred H Miller Multi-phase, multi-compartment and multi-ingredient capsular system
US20050042289A1 (en) * 2003-04-29 2005-02-24 Yamanouchi Pharma Technologies, Inc. Tablets and methods for modified release of hydrophylic and other active agents
WO2005016278A2 (en) 2003-08-12 2005-02-24 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
EP1541129A1 (de) * 2003-12-12 2005-06-15 Cimex AG Amoxycillin und Clavulanat enthaltende pharmazeutische Brauseformulierung
US20070196396A1 (en) * 2004-02-11 2007-08-23 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability
WO2005099672A1 (en) * 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
EP1880716A1 (de) * 2006-07-19 2008-01-23 Sandoz AG Kit enthaltend einen säureempfindlichen pharmazeutischen Wirkstoff sowie einen säurestabilen pharmazeutischen Wirkstoff
AU2006349402A1 (en) * 2006-10-10 2008-04-17 Penwest Pharmaceuticals Co. Robust sustained release formulations
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
TR201000687A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
CN107613789A (zh) 2015-04-07 2018-01-19 丘奇和德怀特有限公司 具有软核的多组分软糖组合物
CN109394718B (zh) * 2018-11-15 2021-04-27 石药集团中诺药业（石家庄）有限公司 一种阿莫西林分散片及其制备方法
CN110051637A (zh) * 2019-05-21 2019-07-26 葵花药业集团北京药物研究院有限公司 阿莫西林克拉维酸钾制剂及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2964817D1 (en) * 1978-09-06 1983-03-24 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
GB9007945D0 (en) * 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
JPH08505868A (ja) * 1993-01-22 1996-06-25 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー クラブラン酸のみまたは他のベータ−ラクタム抗生物質と混合されたクラブラン酸からなる薬剤処方
GB9311030D0 (en) * 1993-05-28 1993-07-14 Smithkline Beecham Corp Pharmaceutical formulations
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
ITMI941169A1 (it) * 1994-06-06 1995-12-06 Smithkline Beecham Farma Formulazioni farmaceutiche
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
GB9416600D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
JP3501289B2 (ja) * 1995-09-07 2004-03-02 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 医薬処方
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
CA2280857A1 (en) * 1997-02-14 1998-08-20 Smithkline Beecham Laboratoires Pharmaceutiques Pharmaceutical formulations comprising amoxocyllin and clavulanate
WO1998040541A1 (en) * 1997-03-11 1998-09-17 Almag Al Process and apparatus for coating metals
SE9700885D0 (sv) * 1997-03-12 1997-03-12 Astra Ab New pharmaceutical formulation
KR20000076329A (ko) * 1997-03-25 2000-12-26 다케다 야쿠힌 고교 가부시키가이샤 위장 점막 부착성 약제 조성물
JP3746901B2 (ja) * 1997-10-15 2006-02-22 ユニ・チャーム株式会社 開閉自在容器
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
GB9818927D0 (en) * 1998-08-28 1998-10-21 Smithkline Beecham Plc Pharmaceutical formulation
US6225304B1 (en) * 1999-02-17 2001-05-01 Pharmaceutical Solutions, Inc. Soluble forms of amoxicillin and treatment of animals

Also Published As

Publication number Publication date
BRPI0009719B8 (pt) 2021-05-25
CA2366304A1 (en) 2000-10-19
PL339591A1 (en) 2000-10-23
AR031068A1 (es) 2003-09-10
HUP0001471A2 (en) 2001-03-28
ITMI20000788A1 (it) 2001-10-11
CO5170471A1 (es) 2002-06-27
BE1012733A6 (fr) 2001-02-06
JP4880125B2 (ja) 2012-02-22
PT1044680E (pt) 2003-10-31
CA2366304C (en) 2004-06-29
HU0001471D0 (en) 2000-06-28
SK5342000A3 (en) 2000-11-07
DE10017883A1 (de) 2000-10-26
DE60003255T2 (de) 2004-05-06
DK200000602A (da) 2000-10-14
MY119953A (en) 2005-08-30
PT102450A (pt) 2001-02-01
BR0009719A (pt) 2002-01-08
SI20304A (sl) 2001-02-28
BG65006B1 (bg) 2006-12-29
ES2202004T3 (es) 2004-04-01
TWI235067B (en) 2005-07-01
SI1044680T1 (en) 2003-12-31
NO20001870D0 (no) 2000-04-11
FI20000863A (fi) 2000-10-13
EP1044680B1 (de) 2003-06-11
FIU20000164U0 (fi) 2000-04-11
GB0008923D0 (en) 2000-05-31
FR2792198A1 (fr) 2000-10-20
EA004310B1 (ru) 2004-02-26
SE0001330D0 (sv) 2000-04-11
HU229097B1 (en) 2013-07-29
ITMI20000788A0 (it) 2000-04-11
AU767177B2 (en) 2003-11-06
SE0001330L (sv) 2000-10-14
KR100634937B1 (ko) 2006-10-17
CZ298801B6 (cs) 2008-02-06
MXPA01010377A (es) 2002-10-23
FI20000863A0 (fi) 2000-04-11
AP1806A (en) 2007-12-14
AP2001002284A0 (en) 2001-12-31
EP1269997A1 (de) 2003-01-02
GB2351661B (en) 2001-10-10
EP1044680A1 (de) 2000-10-18
NO329694B1 (no) 2010-12-06
EP1270005A3 (de) 2006-05-17
NL1014915A1 (nl) 2000-10-16
JP2002541187A (ja) 2002-12-03
RO120817B1 (ro) 2006-08-30
WO2000061116A2 (en) 2000-10-19
PL197448B1 (pl) 2008-03-31
SK285140B6 (sk) 2006-07-07
EP1270005A2 (de) 2003-01-02
OA11926A (en) 2006-04-12
PE20010053A1 (es) 2001-03-10
CN1382040A (zh) 2002-11-27
ES2190692A1 (es) 2003-08-01
CN100382782C (zh) 2008-04-23
WO2000061116A3 (en) 2001-02-01
BE1013309A5 (fr) 2001-11-06
PT102450B (pt) 2003-09-30
AT4327U1 (de) 2001-06-25
AU5702000A (en) 2000-11-14
IL145580A (en) 2007-05-15
DK200000133U3 (da) 2000-07-28
DZ3150A1 (fr) 2000-10-19
DK1044680T3 (da) 2003-09-29
KR20020015312A (ko) 2002-02-27
DE60003255D1 (de) 2003-07-17
HK1032741A1 (en) 2001-08-03
DE20006626U1 (de) 2000-10-19
IE20000271A1 (en) 2001-04-04
HUP0001471A3 (en) 2001-10-29
ES2190692B1 (es) 2004-11-16
CZ20001311A3 (cs) 2000-11-15
TR200102963T2 (tr) 2002-02-21
EA200101075A1 (ru) 2002-04-25
GR1003560B (el) 2001-03-16
NZ514575A (en) 2004-05-28
BG104329A (en) 2001-11-30
IL145580A0 (en) 2002-11-10
GB2351661A (en) 2001-01-10
NO20001870L (no) 2000-10-16
NL1014914C1 (nl) 2000-10-16
NL1014915C2 (nl) 2001-02-12
JP2011256180A (ja) 2011-12-22
MA25352A1 (fr) 2001-12-31
EP1269996A1 (de) 2003-01-02
BR0009719B1 (pt) 2014-09-30
FI4823U1 (fi) 2001-02-16

Similar Documents

Publication Publication Date Title
ATE242629T1 (de) Neue behandlungsmethode unter verwendung einer hochdosierten form von amoxycillin und kaliumclavulanat
FI112559B (fi) Pietsosähköinen oskillaattori, jänniteohjattu oskillaattori, ja niiden valmistusmenetelmä
DE60025233D1 (de) Verfahren zur beruhigen von menschen unter verwendung von körperpflegemitteln
ATE297754T1 (de) Heilung von bruchverletzungen unter verwendung von pthrp analogen
DE69927022D1 (de) Verfahren zur steuerung der benutzung von softwarekomponenten
DE69610070D1 (de) Verfahren zum abfallfreien herstellen von absorptionskernen und davon abgeleitete gewebeähnliche absorbierende materialien
EE200200242A (et) Meetod suhkurtõve raviks
ID26400A (id) Alat dan metode pengoreksi kesalahan bentuk luar
FI980246A (fi) Menetelmä keittimen käyttämiseksi ja keitin
EE9700198A (et) Meetod ja aparatuur orgaaniliste jäätmete töötlemiseks
DE69841792D1 (de) JNK3-Modulatoren und Verwendungsverfahren dafür
DE69314396T2 (de) Herstellungsverfahren einer Mauerwerkbehandlungszusammensetzung
AU1759501A (en) Method of treating a viral infection using antagonists of macrophage colony stimulating factor
DE69325141D1 (de) Behandlung von lignozellulosehaltigen Materialien
DE59709922D1 (de) Pflaster zur transdermalen anwendung von pergolid
FI93600B (fi) Rikkakasvien torjuntamenetelmä, jossa käytetään diflufenikaania, ja herbisidikoostumus
FI970861A (fi) Menetelmä ja laitteisto syväporausten muotoon vaikuttamiseksi
DE69412178D1 (de) Apparat zur Behandlung von Lagen
DE69410042D1 (de) Esterverbindung, Wirkstoff zur Kontrolle von schädlichen Parasiten diese enthaltend als Wirksubstanz, Zwischenverbindung zur Herstellung der Esterverbindung, sowie Verfahren zur Herstellung der Zwischenverbindung
ATE253366T1 (de) Verwendung von 7-apha-methyl-17-alpha-ethynyl- estrane derivaten zur behandlung von atherosclerose
GB2359548B (en) Composition and method for the treatment of concrete and masonry
UA25349A (uk) Спосіб лікуваhhя гострого деструктивhого паhкреатиту
UA25504A (uk) Спосіб лікуваhhя дисбактеріозу hосоглотки
UA25791A (uk) Спосіб коhтролю ефективhості лікуваhhя стабільhої стеhокардії
BR9601664A (pt) Trava contra a reutilizaçao de seringas descartáveis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1044680

Country of ref document: EP